Invesco Dynamic Biotechnology & Genome ETF (PBE)
- Expense ratio0.56%
- Net assets$430.9M
- Dividend yield1.40%
- 1-year return+37.84%
- Holdings31
PBE ETF price chart
PBE quote & trading statistics
PBE performance
Annual returns & drawdowns →- YTD+21.18%
- 1 year+37.84%
- 3 years+21.96%/yr
- 5 years+6.17%/yr
- 10 years+9.96%/yr
- 1Y volatility
- 16.77%
- 3Y volatility
- 17.55%
- 3Y Sharpe ratio
- 0.88
Returns include reinvested distributions; 3-, 5- and 10-year figures are annualized.
PBE top 10 holdings
All holdings →| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ILMN | Illumina Inc | 5.97% |
| 2 | NTRA | Natera Inc | 5.80% |
| 3 | BIIB | Biogen Inc | 5.53% |
| 4 | GILD | Gilead Sciences Inc | 5.29% |
| 5 | RPRX | Royalty Pharma Plc | 5.15% |
| 6 | AMGN | Amgen Inc | 4.89% |
| 7 | VRTX | Vertex Pharmaceuticals Inc | 4.72% |
| 8 | REGN | Regeneron Pharmaceuticals Inc | 4.66% |
| 9 | MRNA | Moderna Inc | 4.02% |
| 10 | NVAX | Novavax Inc | 3.44% |
The top 10 holdings make up 49.5% of the fund (31 holdings in total). As of October 23, 2026.
About Invesco Dynamic Biotechnology & Genome ETF
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
PBE ETF FAQ
What is the PBE expense ratio?
Invesco Dynamic Biotechnology & Genome ETF has a net expense ratio of 0.56%, or $56.00 a year for every $10,000 invested.
How much money is in PBE?
Invesco Dynamic Biotechnology & Genome ETF has about $430.9M in net assets.
What are the top holdings of PBE?
The largest positions in PBE are Illumina Inc (5.97%), Natera Inc (5.80%), Biogen Inc (5.53%). The fund holds 31 securities in total.
How has PBE performed?
PBE returned +37.84% over the past year and +6.17% a year over the past five years, including reinvested distributions.
Does PBE pay dividends?
PBE has a dividend yield of 1.40% and pays distributions quarterly.
When was PBE launched?
Invesco Dynamic Biotechnology & Genome ETF began trading on June 23, 2005.
ETFs similar to PBE
Funds that track the same index or whose top-10 holdings overlap most with PBE's. Overlap: shared top-10 weight as a share of the larger top-10 total of the two funds.
| Symbol | Fund | Overlap | Expense ratio | Net assets | 1-year return |
|---|---|---|---|---|---|
| PBE | Invesco Dynamic Biotechnology & Genome ETF | — | 0.56% | $430.9M | +37.84% |
| IBB | iShares Biotechnology ETF | 65% | 0.46% | $10.73B | +33.96% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 62% | 0.18% | $113.9M | +38.28% |
| BIS | ProShares UltraShort Nasdaq Biotechnology | 61% | 0.96% | $1.9M | -48.12% |